Proteomic analysis of rat cerebral cortex following subchronic acrolein toxicity

Toxicology and Applied Pharmacology

Volumn 272, Issue 1, 2013, Pages 199-207

  Rashedinia, Marzieh ^a   Lari, Parisa ^a   Abnous, Khalil ^b   Hosseinzadeh, Hossein ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acrolein; Glutathione; Malondialdehyde; Neurotoxicity; Oxidative stress; Proteomics

Indexed keywords

ACROLEIN; BETA SYNUCLEIN; CALCINEURIN; ENOLASE; GLUTATHIONE; MALONALDEHYDE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; CELL COMMUNICATION; CELL TRANSPORT; CONTROLLED STUDY; ENERGY METABOLISM; ENVIRONMENTAL EXPOSURE; LIPID PEROXIDATION; MALE; NEUROTOXICITY; NONHUMAN; PHYSIOLOGICAL PROCESS; PROTEIN EXPRESSION; PROTEOMICS; RAT;

ACROLEIN; GLUTATHIONE; MALONDIALDEHYDE; NEUROTOXICITY; OXIDATIVE STRESS; PROTEOMICS;

ACROLEIN; ANIMALS; BLOTTING, WESTERN; CEREBRAL CORTEX; DATABASES, GENETIC; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENVIRONMENTAL POLLUTANTS; GLUTATHIONE; ISOELECTRIC FOCUSING; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; PROTEOMICS; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

EID: 84882766531     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2013.05.029     Document Type: Article

References (58)

1. Adams J.D., Klaidman L.K. Acrolein-induced oxygen radical formation. Free Radic. Biol. Med. 1993, 15:187-193.
2. Aldini G., Orioli M., Carini M. Protein modification by acrolein: relevance to pathological conditions and inhibition by aldehyde sequestering agents. Mol. Nutr. Food Res. 2011, 55:1301-1319.
3. Arumugam N., Thanislass J., Ragunath K., Niranjali Devaraj S., Devaraj H. Acrolein-induced toxicity-defective mitochondrial function as a possible mechanism. Arch. Environ. Contam. Toxicol. 1999, 36:373-376.
4. Bales J.W., Ma X., Yan H.Q., Jenkins L.W., Dixon C.E. Expression of protein phosphatase 2B (calcineurin) subunit A isoforms in rat hippocampus after traumatic brain injury. J. Neurotrauma 2010, 27:109-120.
5. Batista C., Brito G., Souza M., Leitão B., Cunha F., Ribeiro R. A model of hemorrhagic cystitis induced with acrolein in mice. Braz. J. Med. Biol. Res. 2006, 39:1475-1481.
6. Berridge M.J. Calcium hypothesis of Alzheimer's disease. Pflugers Arch. Eur. J. Physiol. 2010, 459:441-449.
7. 2+-ATPase. Biochim. Biophys. Acta Mol. Basis Dis. 2012, 1822:961-969.
8. Butterfield D.A., Lange M.L.B. Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism. J. Neurochem. 2009, 111:915-933.
9. Calingasan N.Y., Uchida K., Gibson G.E. Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease. J. Neurochem. 1999, 72:751-756.
10. Castegna A., Aksenov M., Aksenova M., Thongboonkerd V., Klein J.B., Pierce W.M., Booze R., Markesbery W.R., Butterfield D.A. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic. Biol. Med. 2002, 33:562-571.
11. Chakrabarti S., Munshi S., Banerjee K., Thakurta I.G., Sinha M., Bagh M.B. Mitochondrial dysfunction during brain aging: role of oxidative stress and modulation by antioxidant supplementation. Aging Dis. 2011, 2:242.
12. Chevallet M., Luche S., Rabilloud T. Silver staining of proteins in polyacrylamide gels. Nat. Protoc. 2006, 1:1852-1858.
13. Chin D., Means A.R. Calmodulin: a prototypical calcium sensor. Trends Cell Biol. 2000, 10:323.
14. Ciavardelli D., Silvestri E., Del Viscovo A., Bomba M., De Gregorio D., Moreno M., Di Ilio C., Goglia F., Canzoniero L., Sensi S. Alterations of brain and cerebellar proteomes linked to A? and tau pathology in a female triple-transgenic murine model of Alzheimer's disease. Cell Death Dis. 2010, 1:e90.
15. Dalle-Donne I., Carini M., Vistoli G., Gamberoni L., Giustarini D., Colombo R., Maffei Facino R., Rossi R., Milzani A., Aldini G. Actin Cys374 as a nucleophilic target of ?, ?-unsaturated aldehydes. Free Radic. Biol. Med. 2007, 42:583-598.
16. DeWoskin R.S., Greenberg M., Pepelko W., Strickland J. Toxicological review of acrolein. Support of Summary Information on the Integrated Risk Information System (IRIS) (CAS No. 107-02-8) 2003, US Environmental Protection Agency, Washington, DC.
17. Faroon O., Roney N., Taylor J., Ashizawa A., Lumpkin M., Plewak D. Acrolein health effects. Toxicol. Ind. Health 2008, 24:447-490.
18. Ferrer I., Perez E., Dalfó E., Barrachina M. Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's disease. Neurosci. Lett. 2007, 415:205-209.
19. Fountoulakis M., Tsangaris G.T., Maris A., Lubec G. The rat brain hippocampus proteome. J. Chromatogr. B 2005, 819:115-129.
20. Ghilarducci D.P., Tjeerdema R.S. Fate and effects of acrolein. Rev. Environ. Contam. Toxicol. 1995, 144:95-146.
21. Hayes J.D., Flanagan J.U., Jowsey I.R. Glutathione transferases. Annu. Rev. Pharmacol. Toxicol. 2005, 45:51-88.
22. Hoyer S. Oxidative metabolism deficiencies in brains of patients with Alzheimer's disease. Acta Neurol. Scand. 2012, 94:18-24.
23. Huang Y.-J., Jin M.-H., Pi R.-B., Zhang J.-J., Ouyang Y., Chao X.-J., Chen M.-H., Liu P.-Q., Yu J.-C., Ramassamy C. Acrolein induces Alzheimer's disease-like pathologies in vitro and in vivo. Toxicol. Lett. 2013, 217:184-191.
24. Ichimiya S., Davis J.G., O'rourke D.M., Katsumata M., Greene M.I. Murine thioredoxin peroxidase delays neuronal apoptosis and is expressed in areas of the brain most susceptible to hypoxic and ischemic injury. DNA Cell Biol. 1997, 16:311-321.
25. Ito D., Tanaka K., Suzuki S., Dembo T., Kosakai A., Fukuuchi Y. Up-regulation of the Ire1-mediated signaling molecule, Bip, in ischemic rat brain. Neuroreport 2001, 12:4023-4028.
26. Jomova K., Vondrakova D., Lawson M., Valko M. Metals, oxidative stress and neurodegenerative disorders. Mol. Cell Biochem. 2010, 345:91-104.
27. Kaibuchi K., Kuroda S., Amano M. Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu. Rev. Biochem. 1999, 68:459-486.
28. Kehrer J.P., Biswal S.S. The molecular effects of acrolein. Toxicol. Sci. 2000, 57:6-15.
29. Leung G., Sun W., Zheng L., Brookes S., Tully M., Shi R. Anti-acrolein treatment improves behavioral outcome and alleviates myelin damage in experimental autoimmune enchephalomyelitis mouse. Neuroscience 2011, 173:150-155.
30. Liu X.H., Ren Z., Zhan R., Wang X.X., Wang X.M., Zhang Z.Q., Leng X., Yang Z.H., Qian L.J. Prohibitin protects against oxidative stress-induced cell injury in cultured neonatal cardiomyocyte. Cell Stress Chaperones 2009, 14:311-319.
31. LoPachin R.M., Barber D.S., Gavin T. Molecular mechanisms of the conjugated alpha, beta-unsaturated carbonyl derivatives: relevance to neurotoxicity and neurodegenerative diseases. Toxicol. Sci. 2008, 104:235-249.
32. LoPachin R.M., Gavin T., Barber D.S. Type-2 alkenes mediate synaptotoxicity in neurodegenerative diseases. Neurotoxicology 2008, 29:871-882.
33. Luo J., Shi R. Acrolein induces axolemmal disruption, oxidative stress, and mitochondrial impairment in spinal cord tissue. Neurochem. Int. 2004, 44:475-486.
34. Luo J., Shi R. Acrolein induces oxidative stress in brain mitochondria. Neurochem. Int. 2005, 46:243-252.
35. Luo J., Robinson J.P., Shi R. Acrolein-induced cell death in PC12 cells: role of mitochondria-mediated oxidative stress. Neurochem. Int. 2005, 47:449-457.
36. Luo J., Hill B.G., Gu Y., Cai J., Srivastava S., Bhatnagar A., Prabhu S.D. Mechanisms of acrolein-induced myocardial dysfunction: implications for environmental and endogenous aldehyde exposure. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H3673-H3684.
37. Mello C.F., Sultana R., Piroddi M., Cai J., Pierce W.M., Klein J.B., Butterfield D.A. Acrolein induces selective protein carbonylation in synaptosomes. Neuroscience 2007, 147:674-679.
38. Mi H., Lazareva-Ulitsky B., Loo R., Kejariwal A., Vandergriff J., Rabkin S., Guo N., Muruganujan A., Doremieux O., Campbell M.J. The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res. 2005, 33:D284-D288.
39. Migliore L., Coppedè F. Environmental-induced oxidative stress in neurodegenerative disorders and aging. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 2009, 674:73-84.
40. Moron M.S., Depierre J.W., Mannervik B. Levels of glutathione, glutathione reductase and glutathione-S-transferase activities in rat lung and liver. Biochim. Biophys. Acta, Gen. Subj. 1979, 582:67-78.
41. Pocernich C.B., Cardin A.L., Racine C.L., Lauderback C.M., Allan Butterfield D. Glutathione elevation and its protective role in acrolein-induced protein damage in synaptosomal membranes: relevance to brain lipid peroxidation in neurodegenerative disease. Neurochem. Int. 2001, 39:141-149.
42. Prince G., Delaere P., Fages C., Lefrancois T., Touret M., Salanon M., Tardy M. Glutamine synthetase (GS) expression is reduced in senile dementia of the Alzheimer type. Neurochem. Int. 1995, 20:859-862.
43. Reed T.T. Lipid peroxidation and neurodegenerative disease. Free Radic. Biol. Med. 2011, 51:1302-1319.
44. Robinson R.A.S., Lange M.B., Sultana R., Galvan V., Fombonne J., Gorostiza O., Zhang J., Warrier G., Cai J., Pierce W.M. Differential expression and redox proteomics analyses of an Alzheimer disease transgenic mouse model: effects of the amyloid-? peptide of amyloid precursor protein. Neuroscience 2011, 177:207-222.
45. Shamoto-Nagai M., Maruyama W., Hashizume Y., Yoshida M., Osawa T., Riederer P., Naoi M. In Parkinsonian substantia nigra, ?-synuclein is modified by acrolein, a lipid-peroxidation product, and accumulates in the dopamine neurons with inhibition of proteasome activity. J. Neural Transm. 2007, 114:1559-1567.
46. Singh M., Nam D.T., Arseneault M., Ramassamy C. Role of by-products of lipid oxidation in Alzheimer's disease brain: a focus on acrolein. J. Alzheimers Dis. 2010, 21:741-756.
47. Sithu S.D., Srivastava S., Siddiqui M.A., Vladykovskaya E., Riggs D.W., Conklin D.J., Haberzettl P., O'Toole T.E., Bhatnagar A., D'Souza S.E. Exposure to acrolein by inhalation causes platelet activation. Toxicol. Appl. Pharmacol. 2010, 248:100-110.
48. Smith C., Carney J., Starke-Reed P., Oliver C., Stadtman E., Floyd R., Markesbery W. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc. Est. Acad. Sci. 1991, 88:10540-10543.
49. Starke D.W., Chen Y., Bapna C.P., Lesnefsky E.J., Mieyal J.J. Sensitivity of protein sulfhydryl repair enzymes to oxidative stress. Free Radic. Biol. Med. 1997, 23:373.
50. Stevens J.F., Maier C.S. Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol. Nutr. Food Res. 2008, 52:7-25.
51. Thompson C.A., Burcham P.C. Genome-wide transcriptional responses to acrolein. Chem. Res. Toxicol. 2008, 21:2245-2256.
52. Uchida K. Current status of acrolein as a lipid peroxidation product. Trends Cardiovasc. Med. 1999, 9:109-113.
53. Uchida K. Role of reactive aldehyde in cardiovascular diseases. Free Radic. Biol. Med. 2000, 28:1685-1696.
54. Venkateshappa C., Harish G., Mahadevan A., Bharath M.S., Shankar S. Elevated oxidative stress and decreased antioxidant function in the human hippocampus and frontal cortex with increasing age: implications for neurodegeneration in Alzheimer's disease. Neurochem. Res. 2012, 37:1601-1614.
55. Waxman E.A., Giasson B.I. Molecular mechanisms of ?-synuclein neurodegeneration. Biochim. Biophys. Acta Mol Basis Dis. 2009, 1792:616-624.
56. Weitzdoerfer R., Fountoulakis M., Lubec G. Reduction of actin-related protein complex 2/3 in fetal Down syndrome brain. Biochem. Biophys. Res. Commun. 2002, 293:836-841.
57. Yavuz Ö., Türközkan N., Dogulu F., Aykol S. The effect of 2-chloroadenosine on lipid peroxide level during experimental cerebral ischemia-reperfusion in gerbils. Free Radic. Biol. Med. 1997, 22:337-341.
58. Yu Z.F., Luo H., Fu W., Mattson M.P. The endoplasmic reticulum stress-responsive protein GRP78 protects neurons against excitotoxicity and apoptosis: suppression of oxidative stress and stabilization of calcium homeostasis. Exp. Neurol. 1999, 155:302-314.